Selma Blair shared an update on her battle with multiple sclerosis (MS), more than seven years after revealing her diagnosis.

An insurance company repeatedly denied a Wisconsin woman coverage for a medication her doctor prescribed to treat her ...

Selma Blair exclusively told PEOPLE that she feels like she’s getting her stamina back amid her journey with multiple ...

Selma Blair shared an update on her multiple sclerosis (MS) after being diagnosed with the autoimmune disease in 2018, while ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Contineum Therapeutics (CTNM) shares fell following the results from its mid-stage trial of PIPE-307, a treatment aimed at ...

“Identifying the causes and risk factors of MS and substantiating the effectiveness of certain interventions are both crucial ...

The actress -- who was diagnosed with MS in 2018 -- opened up about her battle with the disease, giving a positive update on her health journey.

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...